Literature DB >> 24030443

Autologous meatal skin graft implantation and intratympanic injection of Pseudomonas aeruginosa: a new experimental mouse model of acquired middle ear cholesteatoma.

Yu Si1, Yu Bin Chen, Qia Xin Chen, Yi Liu, Huai Li Jiang, Zhi Gang Zhang, Xi Huang.   

Abstract

AIM: To create an experimental model for the biomedical research of middle ear cholesteatoma.
METHODS: Cholesteatoma was induced in the right ears of mice. An autologous meatal skin graft was implanted into the middle ear via the tympanic membrane followed by an intratympanic injection of Pseudomonas aeruginosa. Six weeks after surgery, the formation of acquired cholesteatoma was evaluated by macroscopic examination, CT scan, and histological analysis. The expressions of TNF-α, IL-1β, and IL-6 were measured with real-time PCR. Auditory-evoked brain stem response was used for assessing the changes in hearing levels.
RESULTS: None of the mice died during the modeling time. By the sixth postoperative week, cholesteatoma had successfully formed in 23 out of 25 mice, which equals a success rate of 92%. A CT scan revealed that the cholesteatoma was eroding the cochlea. Furthermore, histological analysis demonstrated a cystic structure covered by stratified squamous epithelium and keratin desquamation in the lamellae inside the cystic cavity in the bullae. All mice with experimentally induced cholesteatoma showed hearing impairment and an upregulated expression of TNF-α, IL-1β, and IL-6.
CONCLUSION: The present study successfully developed a mouse model of acquired middle ear cholesteatoma, which provides an extremely valuable tool for auditory and biomedical research. The modeling approach is technically easy and has a high success rate.
© 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24030443     DOI: 10.1159/000354348

Source DB:  PubMed          Journal:  ORL J Otorhinolaryngol Relat Spec        ISSN: 0301-1569            Impact factor:   1.538


  2 in total

1.  TLR4 drives the pathogenesis of acquired cholesteatoma by promoting local inflammation and bone destruction.

Authors:  Yu Si; Yu Bin Chen; Sui Jun Chen; Yi Qing Zheng; Xiang Liu; Yi Liu; Huai Li Jiang; Guo Xu; Zhuo Hao Li; Qiu Hong Huang; Hao Xiong; Zhi Gang Zhang
Journal:  Sci Rep       Date:  2015-12-07       Impact factor: 4.379

2.  TREM-2 promotes acquired cholesteatoma-induced bone destruction by modulating TLR4 signaling pathway and osteoclasts activation.

Authors:  Huaili Jiang; Yu Si; Zhuohao Li; Xi Huang; Suijun Chen; Yiqing Zheng; Guo Xu; Ximing Chen; Yubin Chen; Yi Liu; Hao Xiong; Qiuhong Huang; Maojin Liang; Zhigang Zhang
Journal:  Sci Rep       Date:  2016-12-09       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.